Great Neck, NY, United States of America

Shahin Rafii

USPTO Granted Patents = 18 (Patent Applications = 7)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 119(Granted Patents)

Location History:

Great Neck, NY (US) (2005 - 2018)
New York, NY (US) (2011 - 2024)
Ithaca, NY (US) (2024)

Company Filing History:

14 out of 1,521

Cornell Research Foundation Inc.

patents

5 out of 512

Sloan-kettering Institute for Cancer Research

Children's Medical Center Corporation

patents

5. 1 out of 1

Imclone System Incorporated

patent

where one patent can have more than one assignee

Years Active: 2005-2024

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11932876 - Stable three-dimensional blood vessels and methods for forming the same (2024-03-19),

2. 11913021 - Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis (2024-02-27),

3. 10946066 - Methods for organ regeneration (2021-03-16),

4. 10865379 - Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis (2020-12-15),

5. 9944897 - Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis (2018-04-17),

6. 9927444 - Bone marrow-derived hematopoietic progenitor cells and endothelial progenitor cells as prognostic indicators for cancer (2018-03-27),

7. 9637723 - Generation of functional and durable endothelial cells from human amniotic fluid-derived cells (2017-05-02),

8. 9179654 - Inhibition of angiogenesis (2015-11-10),

9. 8853163 - Methods for increasing vascular density and maintaining viability of microvascular endothelial cells using trk receptor ligands (2014-10-07),

10. 8465738 - Use of vascular endothelial growth factor receptor 1+ cells in treating and monitoring cancer and in screening for chemotherapeutics (2013-06-18),

11. 8465732 - Endothelial cells expressing adenovirus E4ORF1 and methods of use thereof (2013-06-18),

12. 8043803 - Slitrks as markers for stem and progenitor cells and methods of use thereof (2011-10-25),

13. 7723293 - Methods for increasing capillary density and maintaining viability of microvascular cardiac endothelial cells using trk receptor ligands (2010-05-25),

14. 7598043 - Use of vascular endothelial growth factor receptor 1+ cells in treating and monitoring cancer and in screening for chemotherapeutics (2009-10-06),

15. 7514261 - Platelet-derived growth factor protection of cardiac myocardium (2009-04-07),

Title: Shahin Rafii - Pioneering Inventor from Great Neck, NY

Introduction: Shahin Rafii is a renowned inventor based in Great Neck, NY, known for his groundbreaking contributions to the field of biotechnology and medical research.

Latest Patents: Shahin Rafii holds several patents related to innovative medical devices and biotechnological advancements, with a focus on improving patient outcomes and advancing scientific knowledge.

Career Highlights: Throughout his illustrious career, Shahin Rafii has been instrumental in developing cutting-edge technologies that have revolutionized the medical industry. His work has led to significant advancements in areas such as regenerative medicine and stem cell research.

Collaborations: Shahin Rafii has collaborated with leading researchers, scientists, and medical professionals from around the world to further his innovative projects. His collaborative efforts have resulted in the development of novel treatments and therapies that have the potential to transform healthcare practices.

Conclusion: Shahin Rafii's dedication to innovation and his relentless pursuit of scientific excellence have established him as a pioneering figure in the field of biotechnology and medical research. His contributions continue to inspire future generations of inventors and researchers to push the boundaries of what is possible in the realm of medical science.

This text is generated by artificial intelligence and may not be accurate.